Skip to main content

Table 1 Comorbidities in the past five years and antihypertensive care in the past 18 months in the total population above 30 years of age with a hypertension diagnosis in the past five years in the Stockholm Region, who have a primary care contact in the last 3 year. Results by sex and for the total population

From: Differences between private and public primary health care centers and differences between men and women in antihypertensive care and cardiovascular prevention in all patients with hypertension treated in primary care in Stockholm County, Sweden

 

Men

(N = 58239)

Women

(N = 61028)

P-value

Overall

(N = 119267)

Age

    

 Mean (SD)

67.0 (12.5)

69.9 (12.7)

< 0.001

68.4 (12.7)

 Median [Min, Max]

68.0 [30.0, 103]

71.0 [30.0, 109]

 

70.0 [30.0, 109]

Diabetes

16,843 (28.9%)

12,453 (20.4%)

< 0.001

29,296 (24.6%)

Stroke

2188 (3.8%)

1752 (2.9%)

< 0.001

3940 (3.3%)

Coronary heart disease (CHD)

8702 (14.9%)

4911 (8.1%)

< 0.001

13,613 (11.4%)

Atrial fibrillation (AF)

8077 (13.9%)

6238 (10.2%)

< 0.001

14,315 (12.0%)

Gout

3863 (6.6%)

1534 (2.5%)

< 0.001

5397 (4.5%)

Congestive heart failure

4695 (8.1%)

4049 (6.6%)

< 0.001

8744 (7.3%)

Dementia

153 (0.3%)

143 (0.2%)

0.35

296 (0.3%)

Obesity

5064 (8.7%)

5792 (9.5%)

< 0.001

10,856 (9.1%)

Antihypertensive therapy

51,146 (96.9%)

53,476 (96.4%)

< 0.001

104,622 (96.6%)

One antihypertensive drug

1652 (3.1%)

2013 (3.63%)

< 0.001

3665 (3.4%)

Two antihypertensive drugs

17,781 (33.7%)

21,403 (38.6%)

< 0.001

39,184 (36.2%)

Three or more antihypertensive drugs

33,365 (63.2%)

32,073 (57.8%)

< 0.001

65,438 (60.4%)

Thiazides

11,510 (21.8%)

11,852 (21.4%)

0.079

23,362 (21.6%)

Calcium antagonists

24,982 (47.3%)

22,937 (41.3%)

< 0.001

47,919 (44.3%)

Angiotensin receptor blockers

21,998 (41.7%)

24,858 (44.8%)

< 0.001

46,856 (43.3%)

ACE inhibitors

21,622 (41.0%)

17,002 (30.6%)

< 0.001

38,624 (35.7%)

Beta blockers

21,321 (40.4%)

22,690 (40.9%)

0.09

44,011 (40.6%)

Aldosterone antagonists

2461 (4.7%)

2235 (4.0%)

< 0.001

4696 (4.3%)

Other potassium saving agents

26 (0.0%)

38 (0.1%)

0.24

64 (0.1%)

Aspirin in patients with CHD

6270 (72.1%)

3181 (64.8%)

< 0.001

9451 (69.4%)

Statin in patients with CHD/AF/diabetes/stroke

17,062 (62.8%)

11,189 (54.4%)

< 0.001

28,251 (59.1%)

Statin in patients without CHD/AF/diabetes/stroke

7978 (25.7%)

9683 (23.9%)

< 0.001

17,661 (24.7%)

Anticoagulants or aspirin in patients with stroke

1858 (84.9%)

1468 (83.8%)

0.36

3326 (84.4%)

Tobacco counseling

1810 (3.2%)

2180 (3.7%)

< 0.001

3990 (3.5%)

Alcohol counseling

1725 (3.1%)

707 (1.2%)

< 0.001

2432 (2.1%)

Physical activity counseling

16,313 (29.1%)

15,678 (26.5%)

< 0.001

31,991 (27.7%)

Unhealthy diet counseling

13,284 (23.7%)

11,261 (19.0%)

< 0.001

24,545 (21.3%)

Counseling lifestyle

16,839 (30.0%)

15,437 (26.1%)

< 0.001

32,276 (28.0%)

  1. CHD coronary heart disease; AF atrial fibrillation